lawsuits
 

Xarelto Lawsuit

Open

Did Bayer/Johnson & Johnson overstate Xarelto's benefits while downplaying its bleeding risks? That's what thousands of Xarelto lawsuits claim.

 

Victoza Lawsuit

Open

More than 700 lawsuits allege that Victoza, Byetta, and Januvia increase patients' risk of pancreatic cancer. But manufacturers, plaintiffs allege, failed to warn doctors and patients.

 

Zostavax Lawsuit

Open

Merck faces lawsuits for its shingles vaccine, Zostavax. Plaintiffs allege that Zostavax caused serious injuries like shingles, blindness, and even death.

 

TDF HIV Drugs Lawsuit

Open

TDF drugs are allegedly linked to kidney and bone injuries. Lawsuits will maintain that Gilead withheld a less toxic HIV drug in order to maximize profits.

 

Tasigna Lawsuit

Open

Some lawsuits allege that Novartis failed to warn of Tasigna's risk of atherosclerosis, a disease that causes plaque to build up in the arteries.

 

Pradaxa Lawsuit

Open

The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015. They now face thousands of lawsuits.

 

Actemra Lawsuit

Under Investigation

ClassAction.com is investigating possible Actemra lawsuits against Roche for allegedly failing to warn about heart, lung, and pancreatic side effects.

 

Kombiglyze XR Lawsuit

Open

Dozens of patients have filed lawsuits against AstraZeneca alleging the company failed to warn of Kombiglyze XR's heart failure risk.

 

Onglyza Lawsuit

Open

Onglyza lawsuits allege that drugmaker AstraZeneca for years knew about heart failure risks but failed to adequately warn doctors and patients.

 

Taxotere Lawsuit

Open

Lawsuits allege that drugmaker Sanofi hid Taxotere's permanent hair loss risks while falsely and illegally promoting the drug to increase profits.

 

Testosterone Therapy Lawsuit

Open

Testosterone therapy manufacturers aggressively marketed their products to men and did not properly warn of cardiovascular side effects, according to lawsuits.

 

Invokana Lawsuit

Closed

Invokana lawsuits claim that Janssen failed to warn that the diabetes drug could cause diabetic ketoacidosis (DKA) and other serious side effects.

Next Page
Frequently Asked Questions